ZYME Zymeworks Inc.
8-K Current Report
Filed: March 2, 2026
Health Care
Pharmaceutical PreparationsZymeworks Inc. (ZYME) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 2.02: Results of Operations and Financial Condition
- Item 7.01: Regulation FD Disclosure
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings released March 2, 2026 — full results in Exhibit 99.1
- • Period covered: three months and full year ended December 31, 2025
Item 7.01 · Regulation FD Disclosure
- • Reg FD notice listing official disclosure channels: SEC filings, press releases, website, and social media (X @ZymeworksInc, LinkedIn)
- • Investors should monitor ir.zymeworks.com and social channels — material news may appear there first before broader distribution
Other Zymeworks Inc. 8-K Filings
Get deeper insights on Zymeworks Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.